{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:26Z","timestamp":1786112786357,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Heilongjiang University Student Innovation and Entrepreneurship Training Program","award":["S202410229044"],"award-info":[{"award-number":["S202410229044"]}]},{"name":"Wuhu City Science and Technology Plan Project","award":["2024kj082"],"award-info":[{"award-number":["2024kj082"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study aimed to assess macrolide resistance and the genotype distribution of\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      (MP) in children and identify the risk factors for refractory MP pneumonia (RMPP) during the initial post-COVID-19 outbreak in Wuhu. This retrospective study enrolled children with MPP in Wuhu (November 2023\u2013May 2024). Using preserved nasopharyngeal swabs, macrolide resistance mutations were identified by sequencing the 23S rRNA domain V, and genotyping was performed by PCR. Clinical and laboratory parameters were analyzed to identify the risk factors associated with RMPP. An analysis of 296 pediatric MPP patients revealed universal cough (100%), with high rates of fever (94.93%) and sputum (71.62%). Common findings included moist rales (53.04%) and lobar pneumonia (37.5%). Genotype I (87.84%) predominated and showed a higher A2063G resistance mutation rate than genotype II (74.23% vs 55.56%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.019). This mutation was associated with longer hospitalization, more vomiting, and higher C-reactive protein (CRP). RMPP (69.26%) was notable for producing more severe symptoms, higher inflammatory markers (CRP, lactate dehydrogenase [LDH], procalcitonin [PCT], D-D dimer), and a greater need for bronchoscopy and steroid use. Multivariate logistic regression identified prolonged hospitalization, the presence of pulmonary infiltrates, CRP\u2005&gt;\u200510\u2009mg\/L, LDH\u2005&gt;\u2005246 U\/L, and D-D dimer\u2005&gt;\u20050.50 \u03bcg\/mL as independent risk factors for RMPP. Subsequent receiver operating characteristic curve analysis demonstrated the predictive utility of D-D dimer and LDH levels. The present study established genotype I MP with A2063G-mediated macrolide resistance as the predominant epidemic variant in Wuhu. Independent risk factors for RMPP included a prolonged hospital stay and elevated CRP, LDH and D-D dimer. LDH combined with D-D dimer served as a valuable co-marker for early risk stratification and prediction of refractory disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048663","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:02:45Z","timestamp":1778745765000},"page":"e48663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Macrolide resistance and risk factors for refractory Mycoplasma pneumoniae pneumonia in pediatric patients from Wuhu, China: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Tian","family":"Jiang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xiang","sequence":"additional","affiliation":[{"name":"School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University, Wuhu, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-7651","authenticated-orcid":false,"given":"Minmin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Affiliated Wuhu Hospital of East China Normal University (The Second People\u2019s Hospital of Wuhu City), Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12887-025-05435-9","article-title":"Comparison of the epidemiological characteristics of Mycoplasma pneumoniae infections among children during two epidemics in Wuhan from 2018 to 2024.","volume":"25","author":"Mao","year":"2025","journal-title":"BMC Pediatr"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"1900112","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","article-title":"Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.","volume":"25","author":"Beeton","year":"2020","journal-title":"Euro Surveill"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"2100746","DOI":"10.2807\/1560-7917.ES.2022.27.19.2100746","article-title":"Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.","volume":"27","author":"Meyer Sauteur","year":"2022","journal-title":"Euro Surveill"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2666-5247(22)00190-2","article-title":"Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?","volume":"3","author":"Meyer Sauteur","year":"2022","journal-title":"Lancet Microbe"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"2300704","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300704","article-title":"Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023.","volume":"29","author":"Gong","year":"2024","journal-title":"Euro Surveill"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"2332680","DOI":"10.1080\/22221751.2024.2332680","article-title":"Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain.","volume":"13","author":"Urbieta","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12985-024-02458-z","article-title":"Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic.","volume":"21","author":"Li","year":"2024","journal-title":"Virol J"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.2147\/JIR.S491981","article-title":"The clinical significance of pathogen loads and macrolide resistance levels for macrolide-resistant Mycoplasma pneumoniae pneumonia in children.","volume":"17","author":"Leng","year":"2024","journal-title":"J Inflamm Res"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","article-title":"Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.","volume":"48","author":"Matsuoka","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/AAC.04308-14","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"3000605211016376","DOI":"10.1177\/03000605211016376","article-title":"Mutations in domain V of Mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China.","volume":"49","author":"Xu","year":"2021","journal-title":"J Int Med Res"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","article-title":"Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.","volume":"45","author":"Okazaki","year":"2001","journal-title":"Microbiol Immunol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"1449511","DOI":"10.3389\/fmicb.2024.1449511","article-title":"Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in Beijing, China in 2023.","volume":"15","author":"Chen","year":"2024","journal-title":"Front Microbiol"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3201\/eid3005.231632","article-title":"Novel variant and known mutation in 23S rRNA gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.","volume":"30","author":"Nguyen","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond.","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/AAC.01563-08","article-title":"Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.","volume":"53","author":"Xin","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12879-025-10964-w","article-title":"Genotyping and refractory risk factors of Mycoplasma pneumoniae pneumonia in Suzhou, China.","volume":"25","author":"Gu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"934","DOI":"10.46234\/ccdcw2024.196","article-title":"Socioeconomic impact and response strategies to the multifaceted respiratory illness outbreak in Northern China: beyond influenza a and Mycoplasma pneumoniae.","volume":"6","author":"Wang","year":"2024","journal-title":"China CDC Wkly"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","article-title":"Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020.","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0300060517716312","article-title":"Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.","volume":"46","author":"Deng","year":"2018","journal-title":"J Int Med Res"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","article-title":"Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jmii.2021.09.010","article-title":"The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019\u20132020.","volume":"55","author":"Kuo","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ppul.24327","article-title":"Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children.","volume":"54","author":"Yan","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"e0209938","DOI":"10.1371\/journal.pone.0209938","article-title":"Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains.","volume":"14","author":"Katsukawa","year":"2019","journal-title":"PLoS One"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"e24894","DOI":"10.1097\/MD.0000000000024894","article-title":"The risk factors of children acquiring refractory Mycoplasma pneumoniae pneumonia: a meta-analysis.","volume":"100","author":"Gong","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/crj.13620","article-title":"Clinical characteristics and serum inflammatory markers of community-acquired Mycoplasma pneumonia in children.","volume":"17","author":"Fan","year":"2023","journal-title":"Clin Respir J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:46Z","timestamp":1785945706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048663","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}